SOP Schmerztherapie auf der Intensivstation

In dieser Rubrik stellen wir Standard Operating Procedures (SOPs) für häufige, intensivmedizinisch relevante Prozesse vor. Die Form ist eher im Sinne einer Schablone zu verstehen, als – durchaus subjektiv gefärbte – Anregung, eigene, auf lokale Gegebenheiten adaptierte stationsinterne SOPs zu entwerfen und zu implementieren.

Playlist „SOPs Intensivmedizin Up2date“

Alle SOPs auf einen Blick

In der Playlist „SOPs Intensivmedizin up2date“ haben wir für Sie alle bisher erschienenen SOPs übersichtlich zusammengestellt. Sie erreichen die Playlist über https://eref.thieme.de/AEX8 G

Publication History

Article published online:
28 May 2020

• Literatur

• 1 Puntillo KA, Max A, Timsit JF. et al. Determinants of procedural pain intensity in the intensive care unit. The Europain^® Study. Am J Respir Crit Care Med 2014; 189: 39-47 doi:10.1164/rccm.201306-1174OC
• 2 Chahraoui K, Laurent A, Bioy A. et al. Psychological experience of patients 3 months after a stay in the intensive care unit: A descriptive and qualitative study. J Crit Care 2015; 30: 599-605 doi:10.1016/j.jcrc.2015.02.016
• 3 Chanques G, Jaber S, Barbotte E. et al. Impact of systematic evaluation of pain and agitation in an intensive care unit. Crit Care Med 2006; 34: 1691-1699 doi:10.1097/01.CCM.0000218416.62457.56
• 4 Choi J, Hoffman LA, Schulz R. et al. Self-reported physical symptoms in intensive care unit (ICU) survivors: pilot exploration over four months post-ICU discharge. J Pain Symptom Manage 2014; 47: 257-270 doi:10.1016/j.jpainsymman.2013.03.019
• 5 Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI), Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI). S3-Leitlinie: Analgesie, Sedierung und Delirmanagement in der Intensivmedizin (DAS-Leitlinie 2015). AWMF-Register-Nr. 001/012. Im Internet: https://www.awmf.org/leitlinien/detail/ll/001-012.html. Stand: 12.02.2020
• 6 Maier C, Nestler N, Richter H. et al. The Quality of Pain Management in German Hospitals. Dtsch Arztebl Int 2010; 107: 607-614 doi:10.3238/arztebl.2010.0607
• 7 Whipple JK, Lewis KS, Quebbeman EJ. et al. Analysis of pain management in critically ill patients. Pharmacotherapy 1995; 15: 592-599 doi:10.1002/j.1875-9114.1995.tb02868.x
• 8 Chanques G, Viel E, Constantin JM. et al. The measurement of pain in intensive care unit: comparison of 5 self-report intensity scales. Pain 2010; 151: 711-721 doi:10.1016/j.pain.2010.08.039
• 9 Payen JF, Bru O, Bosson JL. et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med 2001; 29: 2258-2263 doi:10.1097/00003246-200112000-00004
• 10 Rijkenberg S, Stilma W, Endeman H. et al. Pain measurement in mechanically ventilated critically ill patients: Behavioral Pain Scale versus Critical-Care Pain Observation Tool. J Crit Care 2015; 30: 167-172 doi:10.1016/j.jcrc.2014.09.007
• 11 Ballantyne JC, Sullivan MD. Intensity of Chronic Pain – The Wrong Metric?. N Engl J Med 2015; 373: 2098-2099 doi:10.1056/NEJMp1507136
• 12 Siffleet J, Young J, Nikoletti S. et al. Patientsʼ self-report of procedural pain in the intensive care unit. J Clin Nurs 2007; 16: 2142-2148 doi:10.1111/j.1365-2702.2006.01840.x
• 13 Martin J, Franck M, Sigel S. et al. Changes in sedation management in German intensive care units between 2002 and 2006: a national follow-up survey. Crit Care 2007; 11: R124 doi:10.1186/cc6189
• 14 Breen D, Wilmer A, Bodenham A. et al. Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment. Crit Care 2004; 8: R21-R30 doi:10.1186/cc2399
• 15 Breen D, Karabinis A, Malbrain M. et al. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497]. Crit Care 2005; 9: R200-R210 doi:10.1186/cc3495
• 16 Karabinis A, Mandragos K, Stergiopoulos S. et al. Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]. Crit Care 2004; 8: R268-R280 doi:10.1186/cc2896
• 17 Soltesz S, Biedler A, Silomon M. et al. Recovery after remifentanil and sufentanil for analgesia and sedation of mechanically ventilated patients after trauma or major surgery. Br J Anaesth 2001; 86: 763-768 doi:10.1093/bja/86.6.763
• 18 Pitsiu M, Wilmer A, Bodenham A. et al. Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment. Br J Anaesth 2004; 92: 493-503 doi:10.1093/bja/aeh086
• 19 Rozendaal FW, Spronk PE, Snellen FF. et al. Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med 2009; 35: 291-298 doi:10.1007/s00134-008-1328-9
• 20 Zhu Y, Wang Y, Du B. et al. Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? A systematic review and meta-analysis. Crit Care 2017; 21: 206 doi:10.1186/s13054-017-1789-8
• 21 Hudcova J, McNicol E, Quah C. et al. Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain. Cochrane Database Syst Rev 2006; (04) CD003348 DOI: 10.1002/14651858.CD003348.pub2.
• 22 Hakkarainen TW, Steele SR, Bastaworous A. et al. Nonsteroidal anti-inflammatory drugs and the risk for anastomotic failure: a report from Washington Stateʼs Surgical Care and Outcomes Assessment Program (SCOAP). JAMA Surg 2015; 150: 223-228 doi:10.1001/jamasurg.2014.2239
• 23 Yauw STK, Lomme RMLM, van den Broek P. et al. Experimental study of diclofenac and its biliary metabolites on anastomotic healing. BJS Open 2018; 2: 220-228 doi:10.1002/bjs5.63
• 24 Stamer UM, Stammschulte T, Erlenwein J. et al. Empfehlungen zur perioperativen Anwendung von Metamizol. Anästh Intensivmed 2019; 60: 403-409 doi:10.19224/ai2019.403
• 25 Stueber T, Buessecker L, Leffler A. et al. The use of dipyrone in the ICU is associated with acute kidney injury: a retrospective cohort analysis. Eur J Anaesthesiol 2017; 34: 673-680 doi:10.1097/EJA.0000000000000627
• 26 Moore RA, Derry S, Aldington D. et al. Single dose oral analgesics for acute postoperative pain in adults-an overview of Cochrane reviews. Cochrane Database Syst Rev 2015; (09) CD008659 DOI: 10.1002/14651858.CD008659.pub3.
• 27 Cruz P, Garutti I, Diaz S. et al. Metamizol versus propacetamol: comparative study of the hemodynamic and antipyretic effects in critically ill patients. Rev Esp Anestesiol Reanim 2002; 49: 391-396
• 28 Qiu H, Sun Z, Shadhiya F. et al. The influence of dexmedetomidine on remifentanil-induced hyperalgesia and the sex differences. Exp Ther Med 2018; 16: 3596-3602 doi:10.3892/etm.2018.6641
• 29 Feng M, Chen X, Liu T. et al. Dexmedetomidine and sufentanil combination versus sufentanil alone for postoperative intravenous patient-controlled analgesia: a systematic review and meta-analysis of randomized controlled trials. BMC Anesthesiology 2019; 19: 81 doi:10.1186/s12871-019-0756-0
• 30 Peng K, Liu HY, Wu SR. et al. Effects of Combining Dexmedetomidine and Opioids for Postoperative Intravenous Patient-controlled Analgesia: A Systematic Review and Meta-analysis. Clin J Pain 2015; 31: 1097-1104 doi:10.1097/AJP.0000000000000219
• 31 Weibel S, Jokinen J, Pace NL. et al. Efficacy and safety of intravenous lidocaine for postoperative analgesia and recovery after surgery: a systematic review with trial sequential analysis. Br J Anaesth 2016; 116: 770-783 doi:10.1093/bja/aew101
• 32 Herminghaus A, Wachowiak M, Wilhelm W. et al. Intravenös verabreichtes Lidocain zur perioperativen Schmerztherapie – Übersicht und praktische Handlungsempfehlungen. Anaesthesist 2011; 60: 152-160 doi:10.1007/s00101-010-1829-0
• 33 Rose K, Meissner W. Schmerztherapie bei Intensivpatienten. Anaesthesist 2018; 67: 401-408 doi:10.1007/s00101-018-0458-x
• 34 Pöpping DM, Elia N, Marret E. et al. Protective effects of epidural analgesia on pulmonary complications after abdominal and thoracic surgery: a meta-analysis. Arch Surg 2008; 143: 990-999 doi:10.1001/archsurg.143.10.990 discussion 1000
• 35 Guay J, Kopp S. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. Cochrane Database Syst Rev 2016; (01) CD005059 DOI: 10.1002/14651858.CD005059.pub4.
• 36 Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin. S1-Leitlinie: Rückenmarksnahe Regionalanästhesien und Thrombembolieprophylaxe/antithrombotische Medikation (Stand 07/2014). AWMF-Register-Nr. 001/005. Im Internet: https://www.awmf.org/leitlinien/detail/ll/001-005.html. Stand: 12.02.2020
• 37 Gelinas C, Arbour C, Michaud C. et al. Patients and ICU nursesʼ perspectives of non-pharmacological interventions for pain management. Nurs Crit Care 2013; 18: 307-318 doi:10.1111/j.1478-5153.2012.00531.x